Posts by: Ines Martins, PhD

Ines Martins, PhD

Inês Martins holds a BSc in Cell and Molecular Biology from Universidade Nova de Lisboa and is currently finishing her PhD in Biomedical Sciences at Universidade de Lisboa. Her work has been focused on blood vessels and their role in both hematopoiesis and cancer development.

September 1, 2016September 1, 2016

In Certain CTEPH Patients, Vascular Remodeling May Lead to Hypoxemia

News

Patients with chronic thromboembolic pulmonary hypertension (CTEPH) who are successfully treated with pulmonary endarterectomy (PEA) may be at increased risk of having low levels of oxygen in the blood ... Read more

August 30, 2016August 30, 2016

Pulmonary Hypertension Seen as Prevalent Among HIV-infected Patients in Africa

News

People infected with HIV are known to have a greater incidence of pulmonary hypertension and to be an almost 2,500-fold higher risk of developing PH than others, and a new study ... Read more

August 26, 2016August 26, 2016

Vascular Constrictor Seen as Target in Treating Pulmonary Arterial Hypertension

News, PAH News

The vascular constrictor coupling factor 6 (CF6) is involved in the development of pulmonary arterial hypertension by creating an imbalance in the inner lining of lung blood vessels, part of ... Read more

August 16, 2016August 16, 2016

Reata Releases Update on Clinical Program, Including Phase 2 Study in PH and PAH Patients

News

Reata Pharmaceuticals recently provided an update on its clinical candidates and their developmental, including its Phase 2 proof-of-concept studies into bardoxolone methyl as a potential treatment for various types of pulmonary ... Read more

August 12, 2016August 12, 2016

Genetic Mutation in Pulmonary Hypertension Found with Blood Sample Test

News

A research collaboration between Intermountain Medical Center and ARUP Laboratories recently led to the development of a new and simple genomic testing method to diagnose a rare form of pulmonary hypertension (PH) ... Read more

August 11, 2016August 11, 2016

Statins May Boost Efficacy of Rho-Kinase Inhibitors in Pulmonary Arterial Hypertension

News, PAH News, PH News

Statins, the cholesterol lowering drugs, may improve the beneficial effects of Rho-kinase inhibitors in pulmonary arterial hypertension (PAH), according to the results of an animal study performed by researchers ... Read more

August 2, 2016August 2, 2016

Inhibiting a Specific Molecular Chaperone May Help Treat PAH, Animal Study Suggests

News

Inhibiting the molecular chaperone heat shock protein 90 (HSP90) may be a promising therapeutic approach in pulmonary arterial hypertension (PAH), according to an animal study developed by researchers at ... Read more

August 1, 2016August 1, 2016

Gene Therapy Improves PAH Symptoms in Animal Models

News, PAH News

Gene therapy may offer a promising therapeutic approach for pulmonary arterial hypertension (PAH), according to an animal study conducted by Japanese researchers. The study “Constitutively active form of natriuretic peptide receptor ... Read more

July 28, 2016July 28, 2016

Phase 2 Trial to Test INOpulse in Patients with PH and Chronic Obstructive Pulmonary Disease

News

INOpulse, a nitric oxide delivery device that is being developed by Bellerophon Therapeutics, was approved by health authorities in Belgium to be used in a Phase 2 trial in patients with pulmonary hypertension ... Read more

July 18, 2016July 18, 2016

Pulmonary Hypertension Patients with Heart Arrhythmias Face Worse Prognosis

CTEPH News, News, PAH News, PH News

The presence of atrial arrhythmias may help predict unfavorable prognosis in patients with pulmonary hypertension (PH), according to a study published in the Cardiology Journal. The study also showed that ... Read more

Pin It on Pinterest